Logo Image
Opinion|Videos|September 23, 2024

Contemporary Guidelines for CRM Conditions

Key Takeaways

  • Professional organizations have developed guidelines to manage the interconnectivity of CRM conditions, reflecting advancements in understanding cardiovascular, renal, and metabolic health.
  • Recent updates in guidelines include the integration of novel therapeutic agents and personalized treatment strategies, enhancing evidence-based practices.
SHOW MORE

Key opinion leaders review current guidelines for cardiometabolic conditions, emphasizing recent advancements in the field.

Episodes in this series

Video content above is prompted by the following:

  • How do guidelines from professional organizations, including ACC, AHA, ADA, KDIGO, ACE, and DCRMi, address the management and interconnectivity of CRM conditions?
  • How have these guidelines evolved in recent years? What are the notable guideline updates in recent years?
  • What impact have these guidelines had on the treatment outcomes of patients with CRM conditions?
  • What gaps are there in these guidelines regarding the management of CRM conditions?

This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.

Related Content